诺华公司将以30亿美元购买实验性癌症药物, 以促进瘤学发展. Novartis to buy experimental cancer drug for $3 billion to boost oncology pipeline.

诺华公司已同意以30亿美元的价格收购一种实验性癌症治疗方法, Novartis has agreed to a $3 billion deal to acquire an experimental cancer therapy, expanding its oncology drug pipeline. 收购包括目前正在临床试验中的有希望的治疗方法,旨在解决癌症护理方面的未满足需求. The acquisition includes a promising treatment currently in clinical trials, aiming to address unmet needs in cancer care. 这一举动突显了诺华公司对创新癌症治疗的持续投资. The move underscores Novartis’s continued investment in innovative cancer therapies.